W Ichikawa1, Y Sasaki. 1. Department of Clinical Oncology, Saitama Medical School, Saitama 350-049, Japan. wataru@saitama-med.ac.jp
Abstract
BACKGROUND: In advanced gastric cancer, the relationship between tumor response and prognosis is far from clear. METHODS: We performed a pooled analysis on published data from 4593 patients in 25 randomized trials of first-line chemotherapy for advanced gastric cancer. A weighed analysis was used to investigate the correlation between objective response rate (RR) and time to progression (TTP) and overall survival time (OS). RESULTS: A moderate correlation was found between RR and TTP and OS (r = 0.49 and r = 0.45, respectively) in all 25 trials. In treatment arms without new drugs including irinotecan, taxanes, or oxaliplatin, RR also was associated with TTP and OS (r = 0.56 and r = 0.47, respectively). However, no association between RR and OS was found, whereas there was a moderate correlation between RR and TTP (r = 0.41) in treatment arms using new drugs. CONCLUSIONS: Our results indicated that response to treatment was related to TTP and OS. The potential role of objective response as a surrogate in chemotherapy trials of advanced gastric cancer warrants further investigation, especially with regard to treatment with new drugs.
BACKGROUND: In advanced gastric cancer, the relationship between tumor response and prognosis is far from clear. METHODS: We performed a pooled analysis on published data from 4593 patients in 25 randomized trials of first-line chemotherapy for advanced gastric cancer. A weighed analysis was used to investigate the correlation between objective response rate (RR) and time to progression (TTP) and overall survival time (OS). RESULTS: A moderate correlation was found between RR and TTP and OS (r = 0.49 and r = 0.45, respectively) in all 25 trials. In treatment arms without new drugs including irinotecan, taxanes, or oxaliplatin, RR also was associated with TTP and OS (r = 0.56 and r = 0.47, respectively). However, no association between RR and OS was found, whereas there was a moderate correlation between RR and TTP (r = 0.41) in treatment arms using new drugs. CONCLUSIONS: Our results indicated that response to treatment was related to TTP and OS. The potential role of objective response as a surrogate in chemotherapy trials of advanced gastric cancer warrants further investigation, especially with regard to treatment with new drugs.
Authors: J Gallego Plazas; A Arias-Martinez; A Lecumberri; E Martínez de Castro; A Custodio; J M Cano; R Hernandez; A F Montes; I Macias; A Pieras-Lopez; M Diez; L Visa; R V Tocino; N Martínez Lago; M L Limón; M Gil; P Pimentel; M Mangas; M Granja; A M Carnicero; C Hernández Pérez; L G Gonzalez; P Jimenez-Fonseca; A Carmona-Bayonas Journal: ESMO Open Date: 2022-06-14
Authors: G H Bain; E Collie-Duguid; G I Murray; F J Gilbert; A Denison; F McKiddie; T Ahearn; I Fleming; J Leeds; P Phull; K Park; S Nanthakumaran; K M Matula; H I Grabsch; P Tan; A Welch; L Schweiger; A Dahle-Smith; G Urquhart; M Finegan; R D Petty Journal: Br J Cancer Date: 2014-02-25 Impact factor: 7.640
Authors: Y Kishida; M Kawahara; S Teramukai; K Kubota; K Komuta; K Minato; T Mio; Y Fujita; T Yonei; K Nakano; M Tsuboi; K Shibata; S Atagi; T Kawaguchi; K Furuse; M Fukushima Journal: Br J Cancer Date: 2009-09-29 Impact factor: 7.640
Authors: A Sekikawa; H Fukui; X Zhang; T Maruo; T Tsumura; Y Okabe; T Wakasa; Y Osaki; T Chiba; T Tomita; T Oshima; J Watari; H Miwa Journal: Br J Cancer Date: 2013-01-15 Impact factor: 7.640